WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Amedisys, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-08 10:18 am Sale | 2023-12-29 | 13G | Amedisys, Inc. AMED | WELLINGTON MANAGEMENT GROUP LLP | 24 0.000% | -2,802,807 (-100.00%) | Filing |
| 2023-02-06 2:59 pm Purchase | 2022-12-30 | 13G | Amedisys, Inc. AMED | WELLINGTON MANAGEMENT GROUP LLP | 2,802,831 8.630% | 990,420 (+54.65%) | Filing |
| 2022-02-04 09:26 am Sale | 2021-12-31 | 13G | Amedisys, Inc. AMED | WELLINGTON MANAGEMENT GROUP LLP | 1,812,411 5.560% | -633,084 (-25.89%) | Filing |
| 2021-02-04 11:00 am Purchase | 2020-12-31 | 13G | Amedisys, Inc. AMED | WELLINGTON MANAGEMENT GROUP LLP | 2,445,495 7.450% | 2,445,495 (New Position) | Filing |